ARKF vs ARKG
ARK Fintech Innovation ETF vs ARK Genomic Revolution ETF
- • ARKF pays a higher dividend yield (0.10%).
Side-by-side metrics
| Metric | ARKF | ARKG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.75% |
Dividend yield Trailing 12-month yield. | 0.10% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $828M | $1.24B |
YTD return | -10.39% | 7.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.06 | 2.35 |
P/E ratio | 36.52 | — |
Last price | $42.28 | $30.38 |
Inception | — | — |
Issuer | ARK | ARK |
ARKF top holdings
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 9.27% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 5.83% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 5.47% |
| XYZ | Block Inc Class A | 5.31% |
| HOOD | Robinhood Markets Inc Class A | 4.47% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 4.20% |
| TOST | Toast Inc Class A | 4.12% |
| AMD | Advanced Micro Devices Inc | 3.88% |
| AMZN | Amazon.com Inc | 3.87% |
ARKG top holdings
| TEM | Tempus AI Inc Class A common stock | 9.45% |
| TWST | Twist Bioscience Corp | 9.02% |
| CRSP | CRISPR Therapeutics AG | 8.94% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 5.78% |
| BEAM | Beam Therapeutics Inc | 5.44% |
| ABSI | Absci Corp | 4.79% |
| NTRA | Natera Inc | 4.08% |
| ILMN | Illumina Inc | 4.04% |
| NTLA | Intellia Therapeutics Inc | 3.83% |
| PSNL | Personalis Inc | 3.59% |
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services. Managed by ARK, the fund carries $828M in assets under management, an expense ratio of 0.75%, a dividend yield of 0.10%. Its largest holding is Shopify Inc Registered Shs -A- Subord Vtg (SHOP), which represents 9.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 16.4%.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.